Article
The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI Cohort
2025-03-10
Abstract excerpt
<h4>Background</h4> Spinocerebellar ataxia type 3 (SCA3) is one of the most common dominantly inherited ataxia worldwide. Despite research advances, no approved disease-modifying treatment exists, and management focuses on symptom alleviation and functional capacity maximization. Symptomatic treatment guidelines are scarce, leaving decisions to physicians’ discretion. The lack of studies on SCA3 symptom managemen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3ef672e3-db8e-5d6b-913e-457e2c5966bd
- DOI
- 10.1101/2025.03.05.25322961
